Finance
Investors Take Advantage Of -3.17% Loss In Pacific Biosciences of California Inc (NASDAQ: PACB)
Pacific Biosciences of California Inc (NASDAQ:PACB) traded at $3.67 at close of the session on Monday, March 18, made a downward move of -3.17% on